SemBioSys begins phase I/II trial of insulin produced in plant seeds

SemBioSys begins phase I/II trial of insulin produced in plant seeds

Zacks Analyst Blog Highlights: Pfizer, Inc., Bristol-Myers Squibb Co., The Hershey Co., Kimberly Clark Corp. And Companhia De Saneamento Basico Do Estado De SãO Paulo

Zacks Analyst Blog Highlights: Pfizer, Inc., Bristol-Myers Squibb Co., The Hershey Co., Kimberly Clark Corp. And Companhia De Saneamento Basico Do Estado De Sao Paulo

Zacks Bull and Bear of the Day Highlights: SABESP, AutoNation, SiRF Technology, Public Storage and D.R. Horton

SABESP's Net Operating Revenue Grows 6.8% in 3Q08

Sabesp Executes Third Amendment to the GESP Agreement

SemBioSys announces third quarter 2008 financial and operational results

Zacks Analyst Blog Highlights: EOG Resources, Inc., Dr. Pepper Snapple Group Inc., Pepsi Bottling Group, Iconix Brand Group and Companhia De Saneamento Basico Do Estado De Sao Paulo.

SemBioSys announces substantial cost reductions to extend development runway

Botaneco receives natural ingredient approval from ECOCERT(R) for Hydresia(TM) G2

Botaneco receives natural ingredient approval from ECOCERT(R) for Hydresia(TM) G2

SemBioSys eligible to proceed with Phase I/II plant-produced insulin trial after submission of IND

Sabesp Announces Tariff Readjustment

SABESP's Net Revenue Grows 4.5% in 2Q08

SemBioSys announces second quarter 2008 financial and operational results

SemBioSys announces second quarter 2008 financial and operational results

Sabesp Announces Dividend Payment in the Form of Interest on Own Capital

SemBioSys submits IND for safflower-produced insulin to U.S. FDA

Botaneco announces $4,000,000 financing

Botaneco announces $4,000,000 financing

SemBioSys Demonstrates Functionality of its Safflower Produced Apo AI(Milano)

SemBioSys Demonstrates Functionality of its Safflower Produced Apo AI(Milano)

SemBioSys to present at the Needham & Company Biotechnology and Medical Technology Conference

SemBioSys to present at the Needham & Company Biotechnology and Medical Technology Conference

SABESP has Entered into a Confidentiality Agreement With EMAE

SemBioSys provides update on shrimp feed additive, Immunosphere(TM)

SABESP'S Net Revenue Grows 5.2% in 1Q08